🔗 Share this article

As America undertakes unprecedented revisions to its immunization guidelines, an unexpected name appears unexpectedly: Høeg, a US-based physician and epidemiologist who initially gained attention by questioning COVID-19 vaccinations during the global health crisis and has focused upon potential fatalities following Covid vaccination in her short time at the Food and Drug Administration.

Planned Changes to Childhood Immunization Program

Agency leaders had intended to unveil radical changes to the childhood vaccination calendar in December, synchronizing the US with the Danish vaccine program, it is understood – a significant shift that would put the US out of step with much of the international standard with no evidence for public health gain. This reveal has been delayed until the new year.

In place of the director of the vaccine center, Dr. Høeg is set to speak at the meeting. She was just designated temporary leader of the FDA’s drug evaluation center, the fifth appointee to head the center this year.

A Shift at the Agency

This interim role could signify a strengthened alliance between the drug and vaccine branches as Høeg and Prasad solidify control at the agency – and it signals a greater focus upon rolling back long-standing immunizations at the FDA.

Dr. Høeg has repeatedly called for halting some childhood shot schedules in the US in order to be more similar to Denmark, a nation with nationalized medicine and a citizenry about the population of Wisconsin’s.

To date comments, she has kept her attention on vaccination policy – usually the purview of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of medication approval.

Concerns Over Expertise

Dr. Høeg has little discernible background in drug development, oversight or administrative roles, which has been standard for past directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a senior adviser to the FDA chief and CBER since March.

“She appears not to have the requisite experience” for running the CDER, stated a neurologist and psychiatrist. “She’s never run a scientific study. She lacks experience in leading a large organization. She has no expertise in pharmaceutical oversight.”

Past heads of CBER would “be deeply familiar with laws and regulations and the research of medication creation”, commented Janet Woodcock. “Clearly, she doesn’t have the kind of background that former directors who headed the center have had.”

CDER has an vast range of responsibilities at the agency, Woodcock stated.

“Many people just focuses on the novel medication approvals, but the off-patent medication office approves thousands of generic drugs. There is also a biosimilars program, over-the-counter program and so forth, and each of these have to be managed,” Woodcock said. “The responsibility you neglect, that’s the thing that I always told people is going to come back to haunt you.”

There is also, a significant leadership aspect to the position, which supervises more than 5,000 staff members. “It is a enormous leadership role, if you perform it correctly,” she said.

Official Statement and Controversial Policies

In response to inquiries about Dr. Høeg's credentials and whether this appointment indicates increased cooperation among regulatory chiefs on vaccines, a representative responded that the “concerns are based on flawed premises”.

“Her experience is consistent with the functions of her role,” the representative said, noting the months Høeg spent advising the FDA commissioner on “pharmaceutical safety and regulatory science, including predictive safety algorithms and shot safety tracking”.

As the temporary head, Dr. Høeg takes over the agency head's new priority voucher program, a controversial rapid medication authorization process that reportedly troubled her former heads. “By what process are these therapies being chosen for this fast-track system? Who is making the calls?” Howard said. “There’s a lot of lack of transparency going on at the agency right now.”

Overall, he stated, “the FDA appears to be shifting towards more relaxed oversight of most medications, aside from immunizations.”

Established Track Record on Vaccines

With vaccines, Dr. Høeg has a more documented, if problematic, track record, Howard observe. She released a study using unverified crowd-sourced reports to assess the frequency of heart inflammation following COVID-19 immunization. She consulted for the Florida surgeon general Dr. Joseph Ladapo, who allegedly have altered data to suggest Covid vaccines are more dangerous than they are.

Among her “desired changes” for the new government included changing guidelines for new vaccines and ending “non-essential” vaccines, she stated post-election on a online show. At the agency, Dr. Høeg has reportedly suggested preventing adolescent males from obtaining COVID-19 vaccinations.

“She is an complete ideologue who starts off with her conclusions and reverse-engineers to accommodate the data in a extremely disingenuous, untruthful way,” Howard stated.

Gaining Influence and a “Push for Payback”

Dr. Høeg aligned with other skeptics, {like|